J. F. Peppin, DO, FACP, J. J. Coleman, PhD, and K. L. Kirsh, PhD, “Considerations for the upcoming FDA REMS proposal”, J of Opioid Management, vol. 7, no. 3, pp. 173–176, Jan. 2018.